NCT00240344已完成不适用
REALISTIC: Protocol for an Observational Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New EAS LDL-C Target Goal
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 2,650
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is to determine the efficacy of Crestor in high risk patients switched from higher doses of other statins in obtaining the new European Atherosclerosis Society (EAS) low-density lipoprotein cholesterol (LDL-C) guidelines.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 70 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •High risk patients
- •High doses of other statins
- •LDL-C known, starts with Crestor 10 mg
- •Permission to use patient data by AstraZeneca (AZ)
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D PatientsChronic Hepatitis DNCT06051045Karolinska University Hospital400
已完成
不适用
A Feasibility Clinical Trial to Evaluate High Frequency Spinal Cord Stimulation for the Treatment of Patients With Chronic MigraineRefractory Chronic MigraineNCT01653340University of Roma La Sapienza18
招募中
不适用
Study of Innovative Drug Treatment Therapy for Pediatric Mitral RegurgitationCongenital Mitral InsufficiencyNCT06037434China National Center for Cardiovascular Diseases122
招募中
不适用
Study of Innovative Drug Strategies in Improving Left Ventricular Function After Mitral RepairCongenital Mitral InsufficiencyNCT06039592China National Center for Cardiovascular Diseases164
招募中
不适用
Study of Innovative Strategies for Mitral Valve RepairCongenital Mitral InsufficiencyNCT06037447China National Center for Cardiovascular Diseases256
